Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
France- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to France92 clinical trials in Argenteuil, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel treatment combinations and maintenance therapies. Studies include investigations of follicular lymphoma and chronic lymphocytic leukemia treatments.
Particular emphasis on improving patient outcomes through targeted therapies and immunological approaches.
Clinical trials examining treatments for invasive candidiasis and immune system disorders. Research includes studies on immunosuppression prevention and management in intensive care settings.
Focus on developing more effective treatments for both acute and chronic immune conditions.
Studies investigating treatments for asthma and severe respiratory infections, including community-acquired pneumonia. Research includes evaluation of new delivery systems and therapeutic approaches.
Emphasis on improving treatment outcomes and patient quality of life through innovative therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.